"Bacterial Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease.
- Bacterial Vaccines
- Vaccine, Bacterial
- Bacterial Vaccine
- Vaccines, Bacterial
Below are MeSH descriptors whose meaning is more general than "Bacterial Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Bacterial Vaccines".
This graph shows the total number of publications written about "Bacterial Vaccines" by people in this website by year, and whether "Bacterial Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Bacterial Vaccines" by people in Profiles.
Nambiar PH, Daza AD, Livornese LL. Clinical Impact of Vaccine Development. Methods Mol Biol. 2016; 1403:3-39.
Abuali MM, Arnon R, Posada R. An update on immunizations before and after transplantation in the pediatric solid organ transplant recipient. Pediatr Transplant. 2011 Dec; 15(8):770-7.
Mustafa W, Al-Saleem FH, Nasser Z, Olson RM, Mattis JA, Simpson LL, Schnell MJ. Immunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge. Vaccine. 2011 Jun 20; 29(28):4638-45.
Ulland TK, Buchan BW, Ketterer MR, Fernandes-Alnemri T, Meyerholz DK, Apicella MA, Alnemri ES, Jones BD, Nauseef WM, Sutterwala FS. Cutting edge: mutation of Francisella tularensis mviN leads to increased macrophage absent in melanoma 2 inflammasome activation and a loss of virulence. J Immunol. 2010 Sep 1; 185(5):2670-4.
Szaba FM, Kummer LW, Wilhelm LB, Lin JS, Parent MA, Montminy-Paquette SW, Lien E, Johnson LL, Smiley ST. D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague. Infect Immun. 2009 Oct; 77(10):4295-304.
Adekar SP, Jones RM, Elias MD, Al-Saleem FH, Root MJ, Simpson LL, Dessain SK. A human monoclonal antibody that binds serotype A botulinum neurotoxin. Hybridoma (Larchmt). 2008 Feb; 27(1):11-7.
Vogiatzi P, Cassone M, Luzzi I, Lucchetti C, Otvos L, Giordano A. Helicobacter pylori as a class I carcinogen: physiopathology and management strategies. J Cell Biochem. 2007 Oct 01; 102(2):264-73.
Fawcett PT, Rose CD, Maduskuie V. Long-term effects of immunization with recombinant lipoprotein outer surface protein a on serologic test for lyme disease. Clin Diagn Lab Immunol. 2004 Jul; 11(4):808-10.
Fawcett PT, Rose CD, Gibney KM. In vitro assessment of antiborrelial activity of OspA vaccine sera. Clin Diagn Lab Immunol. 2002 Jul; 9(4):919-20.
Shatz DV, Schinsky MF, Pais LB, Romero-Steiner S, Kirton OC, Carlone GM. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy. J Trauma. 1998 May; 44(5):760-5; discussion 765-6.